2410 — TYK Medicines Cashflow Statement
0.000.00%
Last trade - 00:00- HK$3.10bn
- HK$2.86bn
Annual cashflow statement for TYK Medicines, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -312 | -383 | -388 | -306 |
| Depreciation | ||||
| Amortisation | ||||
| Non-Cash Items | 77.1 | 104 | 102 | 0.351 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -1.66 | 51 | -52.1 | 64.8 |
| Change in Accounts Receivable | ||||
| Change in Payable / Accrued Expenses | ||||
| Net Change in Other Assets & Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | -220 | -201 | -308 | -216 |
| Capital Expenditures | -88.2 | -77.3 | -73.6 | -45.2 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | -70 | 150 | -62.2 | 81.2 |
| Acquisition of Business | ||||
| Sale of Fixed Assets | ||||
| Sale/Maturity of Investment | ||||
| Change in Net Investments | ||||
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -158 | 73 | -136 | 36 |
| Financing Cash Flow Items | 27.8 | 55.5 | -68.5 | 12.5 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 351 | 224 | 632 | 126 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -27.1 | 96.1 | 188 | -58.6 |